Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Shortages Defy Easy Solutions, FDA Notes As It Offers Congress Some Ideas

Executive Summary

FDA takes a variety of approaches as it tackles the problem of drug shortages and is tying the high-profile issue to related priorities.

You may also be interested in...



Track and Trace Standards Coming Shortly, FDA Says

Standards were required in FDAAA; industry asked for them in part to avoid conflicts with California pedigree law that will be implemented in 2015.

Drug Shortage Fixes Migrating Toward Economics

After spending time on ideas for early warnings, Congress now is also considering whether economic incentives could prevent shortages.

Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More

Presenters at drug shortage workshop want estimates of the scope and severity of a pending supply interruption to obtain alternative therapies.

Related Content

Topics

UsernamePublicRestriction

Register

PS053789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel